Nerve Central (Kiernan Lab)

Nerve Central (Kiernan Lab) This 17-strong team of clinicians, scientists, biomedical engineers and research students has a multi-focussed approach to neurological disease.

The Kiernan Group was established in 2001, with research labs based at NeuRA, linked to the Prince of Wales Clinical School UNSW and The Institute of Neurological Sciences, Prince of Wales Hospital. The group works in close collaboration with Professor David Burke at the University of Sydney (combined ARC Discovery grant) and Professor Hugh Bostock FRS at The Institute of Neurology, Queen Square, London UK (combined fellowships and program grant collaborations). Current projects are directed to:

- motor neurone disease: establishing the site of onset and mechanisms of progression

-spinal cord injury: prevention of neurological damage following injury
multiple sclerosis, demyelinating neuropathy, neuromuscular disease: delineating mechanisms of fatigue

-neurotoxicity: prevention of nerve damage associated with chemotherapies used in the treatment of cancer

-understanding the development of neurological symptoms associated with nerve crush and ischaemia

-epilepsy and pain-related states: improving the effects of anticonvulsant therapies in treatment

-understanding the process of plasticity of the nervous system in stroke patients and thereby finding ways to improve stroke outcome

We are also conducting clinical trials aimed at neuroprotective and physical therapies in neurological diseases. Our research is intrinsically linked to the provision of local clinical services, particularly the multidisciplinary motor neurone disease clinic; the hereditary nerve and muscle clinics run through Prince of Wales Hospitals; neurological consultation and clinical neurophysiological investigations.

05/06/2020
Australia and specifically NSW, featured in the New England Journal of Medicine regarding its control of the Covid-19 pa...
09/05/2020

Australia and specifically NSW, featured in the New England Journal of Medicine regarding its control of the Covid-19 pandemic

02/05/2020

Many people with amyotrophic lateral sclerosis (ALS) and their caregivers wonder how to stay safe during the COVID-19 pandemic. Our expert weighs in.

Doctors Michelle Farrar, Cindy Lin, and William Huynh featured in highlights from the 2019 Australian and New Zealand as...
29/06/2019

Doctors Michelle Farrar, Cindy Lin, and William Huynh featured in highlights from the 2019 Australian and New Zealand association of neurologists annual conference.

07/06/2019

Prof Matthew Kiernan and his Sydney Forefront MND group.

07/06/2019

A new online matching service, StepUp for Dementia Research, is set to revolutionise the way people with dementia and researchers connect, fast-tracking more effective and inclusive dementia research across Australia.

The U.S. Food and Drug Administration today approved Zolgensma (onasemnogene abeparvovec-xioi), the first gene therapy a...
29/05/2019

The U.S. Food and Drug Administration today approved Zolgensma (onasemnogene abeparvovec-xioi), the first gene therapy approved to treat children less than two years of age with spinal muscular atrophy (SMA), the most severe form of SMA and a leading genetic cause of infant mortality.

FDA Approves Innovative Gene Therapy to Treat Pediatric Patients With Spinal Muscular Atrophy, a Rare Disease and Leading Genetic Cause of Infant Mortality

11/05/2019

Research shows that dance offers a wealth of anti-aging benefits. It’s also fun.

Address

Neuroscience Research Australia & Institute Of Neurological Sciences (Prince Of Wales Hospital)
Randwick, NSW
2031

Telephone

+61293822413

Website

https://www.facebook.com/JNNP.BMJ

Alerts

Be the first to know and let us send you an email when Nerve Central (Kiernan Lab) posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram